# Flyexclusive Inc.: financial statements, quarterly

FLYX · NYSE · CIK 1843973 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/flyx.md) · [Financials](/companies/flyx/financials.md) · [Filings](/companies/flyx/filings.md) · [Insiders](/companies/flyx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/flyx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [62.0](/filings/0001628280-24-047872.md) | [76.0 d](/filings/0001628280-25-014481.md) | [80.0](/filings/0000950170-25-070284.md) | [79.0](/filings/0000950170-25-107987.md) | [76.9](/filings/0001193125-25-277504.md) | [91.4 d](/filings/0001843973-26-000013.md) | [88.1](/filings/0001193125-26-216705.md) | [91.3](/filings/0001193125-26-345831.md) | [92.1](/filings/0001193125-25-277504.md) | [104 d](/filings/0001843973-26-000013.md) | [96.4](/filings/0001193125-26-216705.md) | [111](/filings/0001193125-26-345831.md) |
| Cost of revenue | $m | [63.3](/filings/0001628280-24-047872.md) | [70.6 d](/filings/0001628280-25-014481.md) | [74.2](/filings/0000950170-25-070284.md) | [72.8](/filings/0000950170-25-107987.md) | [68.2](/filings/0001193125-25-277504.md) | [75.0 d](/filings/0001843973-26-000013.md) | [76.8](/filings/0001193125-26-216705.md) | [77.6](/filings/0001193125-26-345831.md) | [79.5](/filings/0001193125-25-277504.md) | [85.7 d](/filings/0001843973-26-000013.md) | [77.3](/filings/0001193125-26-216705.md) | [88.4](/filings/0001193125-26-345831.md) |
| Selling, general and administrative | $m | [17.5](/filings/0001628280-24-047872.md) | [23.5 d](/filings/0001628280-25-014481.md) | [25.2](/filings/0000950170-25-070284.md) | [21.5](/filings/0000950170-25-107987.md) | [20.0](/filings/0001193125-25-277504.md) | [24.7 d](/filings/0001843973-26-000013.md) | [21.0](/filings/0001193125-26-216705.md) | [20.3](/filings/0001193125-26-345831.md) | [19.5](/filings/0001193125-25-277504.md) | [21.8 d](/filings/0001843973-26-000013.md) | [22.7](/filings/0001193125-26-216705.md) | [22.3](/filings/0001193125-26-345831.md) |
| Operating income | $m | [(15.9)](/filings/0001628280-24-047872.md) | [(23.5) d](/filings/0001628280-25-014481.md) | [(27.4)](/filings/0000950170-25-070284.md) | [(21.8)](/filings/0000950170-25-107987.md) | [(20.9)](/filings/0001193125-25-277504.md) | [(12.6) d](/filings/0001843973-26-000013.md) | [(14.7)](/filings/0001193125-26-216705.md) | [(12.4)](/filings/0001193125-26-345831.md) | [(11.3)](/filings/0001193125-25-277504.md) | [(8.8) d](/filings/0001843973-26-000013.md) | [(9.6)](/filings/0001193125-26-216705.md) | [(5.8)](/filings/0001193125-26-345831.md) |
| Interest expense | $m | [5.7](/filings/0001628280-24-047872.md) | [6.6 d](/filings/0001628280-24-019447.md) | [4.7](/filings/0001628280-24-036817.md) | [5.7](/filings/0001628280-24-037173.md) | [5.6](/filings/0001628280-24-047872.md) | [5.2 d](/filings/0001843973-26-000013.md) | [5.4](/filings/0001193125-26-216705.md) | [4.4](/filings/0001193125-26-345831.md) | [5.1](/filings/0001193125-25-277504.md) | [6.5 d](/filings/0001843973-26-000013.md) | [5.3](/filings/0001193125-26-216705.md) | [5.7](/filings/0001193125-26-345831.md) |
| Income tax | $m | [0.0](/filings/0001628280-24-047872.md) | [0.0 d](/filings/0001628280-25-014481.md) | [0.0](/filings/0000950170-25-070284.md) | [0.0](/filings/0000950170-25-107987.md) | [0.0](/filings/0001193125-25-277504.md) | [0.0 d](/filings/0001843973-26-000013.md) | [0.0](/filings/0001193125-26-216705.md) | [0.0](/filings/0001193125-26-345831.md) | [0.0](/filings/0001193125-25-277504.md) | [0.0 d](/filings/0001843973-26-000013.md) | [0.0](/filings/0001193125-26-216705.md) | [0.1](/filings/0001193125-26-345831.md) |
| Net income | $m | [(22.1)](/filings/0001628280-24-047872.md) | [(23.4) d](/filings/0001628280-25-014481.md) | [(5.8)](/filings/0000950170-25-070284.md) | [(5.2)](/filings/0000950170-25-107987.md) | [(6.3)](/filings/0001193125-25-277504.md) | [(3.8) d](/filings/0001843973-26-000013.md) | [(5.4)](/filings/0001193125-26-216705.md) | [(4.8)](/filings/0001193125-26-345831.md) | [(4.3)](/filings/0001193125-25-277504.md) | [(3.2) d](/filings/0001843973-26-000013.md) | [(6.5)](/filings/0001193125-26-216705.md) | [(7.4)](/filings/0001193125-26-345831.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.35)](/filings/0000950170-25-070284.md) | [(0.32)](/filings/0000950170-25-107987.md) | [(0.32)](/filings/0001193125-25-277504.md) | not reported | [(0.30)](/filings/0001193125-26-216705.md) | [(0.26)](/filings/0001193125-26-345831.md) | [(0.25)](/filings/0001193125-25-277504.md) | not reported | [(0.17)](/filings/0001193125-26-216705.md) | [(0.16)](/filings/0001193125-26-345831.md) |
| Basic EPS | $ per share | not reported | not reported | [(0.35)](/filings/0000950170-25-070284.md) | [(0.32)](/filings/0000950170-25-107987.md) | [(0.32)](/filings/0001193125-25-277504.md) | not reported | [(0.30)](/filings/0001193125-26-216705.md) | [(0.26)](/filings/0001193125-26-345831.md) | [(0.25)](/filings/0001193125-25-277504.md) | not reported | [(0.17)](/filings/0001193125-26-216705.md) | [(0.16)](/filings/0001193125-26-345831.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.5](/filings/0001193125-23-279916.md) | [11.6](/filings/0001628280-25-014481.md) | [5.3](/filings/0001628280-24-036817.md) | [9.3](/filings/0001628280-24-037173.md) | [18.7](/filings/0001628280-24-047872.md) | [31.7](/filings/0001843973-26-000013.md) | [14.7](/filings/0000950170-25-070284.md) | [15.8](/filings/0000950170-25-107987.md) | [18.7](/filings/0001193125-25-277504.md) | [29.3](/filings/0001193125-26-345831.md) | [18.7](/filings/0001193125-26-216705.md) | [14.2](/filings/0001193125-26-345831.md) |
| Current assets | $m | [0.5](/filings/0001193125-23-279916.md) | [117](/filings/0001628280-25-014481.md) | [125](/filings/0001628280-24-036817.md) | [128](/filings/0001628280-24-037173.md) | [133](/filings/0001628280-24-047872.md) | [144](/filings/0001843973-26-000013.md) | [66.8](/filings/0000950170-25-070284.md) | [65.5](/filings/0000950170-25-107987.md) | [68.7](/filings/0001193125-25-277504.md) | [74.4](/filings/0001193125-26-345831.md) | [66.7](/filings/0001193125-26-216705.md) | [63.5](/filings/0001193125-26-345831.md) |
| Total assets | $m | [45.7](/filings/0001193125-23-279916.md) | [521](/filings/0001628280-25-014481.md) | [524](/filings/0001628280-24-036817.md) | [495](/filings/0001628280-24-037173.md) | [487](/filings/0001628280-24-047872.md) | [538](/filings/0001843973-26-000013.md) | [467](/filings/0000950170-25-070284.md) | [443](/filings/0000950170-25-107987.md) | [448](/filings/0001193125-25-277504.md) | [440](/filings/0001193125-26-345831.md) | [449](/filings/0001193125-26-216705.md) | [439](/filings/0001193125-26-345831.md) |
| Current liabilities | $m | [8.7](/filings/0001193125-23-279916.md) | [222](/filings/0001628280-25-014481.md) | [208](/filings/0001628280-24-036817.md) | [202](/filings/0001628280-24-037173.md) | [266](/filings/0001628280-24-047872.md) | [295](/filings/0001843973-26-000013.md) | [252](/filings/0000950170-25-070284.md) | [260](/filings/0000950170-25-107987.md) | [276](/filings/0001193125-25-277504.md) | [270](/filings/0001193125-26-345831.md) | [279](/filings/0001193125-26-216705.md) | [278](/filings/0001193125-26-345831.md) |
| Total liabilities | $m | [18.6](/filings/0001193125-23-279916.md) | [486](/filings/0001628280-25-014481.md) | [503](/filings/0001628280-24-036817.md) | [502](/filings/0001628280-24-037173.md) | [496](/filings/0001628280-24-047872.md) | [550](/filings/0001843973-26-000013.md) | [496](/filings/0000950170-25-070284.md) | [496](/filings/0000950170-25-107987.md) | [527](/filings/0001193125-25-277504.md) | [524](/filings/0001193125-26-345831.md) | [522](/filings/0001193125-26-216705.md) | [523](/filings/0001193125-26-345831.md) |
| Long-term debt | $m | not reported | [167](/filings/0001628280-24-019447.md) | [209](/filings/0001628280-24-036817.md) | [206](/filings/0001628280-24-037173.md) | [198](/filings/0001628280-24-047872.md) | [189](/filings/0001628280-25-014481.md) | [122](/filings/0000950170-25-070284.md) | [112](/filings/0000950170-25-107987.md) | [124](/filings/0001193125-25-277504.md) | [109](/filings/0001843973-26-000013.md) | [103](/filings/0001193125-26-216705.md) | [104](/filings/0001193125-26-345831.md) |
| Current portion of debt | $m | not reported | [26.5](/filings/0001628280-25-014481.md) | [24.9](/filings/0001628280-24-036817.md) | [22.8](/filings/0001628280-24-037173.md) | [81.4](/filings/0001628280-24-047872.md) | [84.9](/filings/0001628280-25-014481.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [14.4](/filings/0001628280-25-014481.md) | [6.3](/filings/0001628280-24-036817.md) | [6.2](/filings/0001628280-24-037173.md) | [6.1](/filings/0001628280-24-047872.md) | [6.0](/filings/0001843973-26-000013.md) | [5.3](/filings/0000950170-25-070284.md) | [8.3](/filings/0000950170-25-107987.md) | [9.7](/filings/0001193125-25-277504.md) | [8.5](/filings/0001193125-26-345831.md) | [7.4](/filings/0001193125-26-216705.md) | [6.9](/filings/0001193125-26-345831.md) |
| Shareholders' equity | $m | [(17.4)](/filings/0001193125-23-279916.md) | [46.5](/filings/0001628280-25-014481.md) | [(150)](/filings/0001628280-24-036817.md) | [(150)](/filings/0001628280-24-037173.md) | [(192)](/filings/0001628280-24-047872.md) | [(233)](/filings/0001843973-26-000013.md) | [(281)](/filings/0000950170-25-070284.md) | [(261)](/filings/0000950170-25-107987.md) | [(434)](/filings/0001193125-25-277504.md) | [(327)](/filings/0001193125-26-345831.md) | [(222)](/filings/0001193125-26-216705.md) | [(220)](/filings/0001193125-26-345831.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.9 d](/filings/0001628280-24-047872.md) | [5.0 d](/filings/0001628280-25-014481.md) | [(26.0)](/filings/0000950170-25-070284.md) | [(16.2) d](/filings/0000950170-25-107987.md) | [(12.3) d](/filings/0001193125-25-277504.md) | [43.5 d](/filings/0001843973-26-000013.md) | [(10.5)](/filings/0001193125-26-216705.md) | [0.4 d](/filings/0001193125-26-345831.md) | [(0.2) d](/filings/0001193125-25-277504.md) | [17.0 d](/filings/0001843973-26-000013.md) | [(0.6)](/filings/0001193125-26-216705.md) | [2.7 d](/filings/0001193125-26-345831.md) |
| Capital expenditure | $m | [30.2 d](/filings/0001628280-24-047872.md) | [16.7 d](/filings/0001628280-25-014481.md) | [38.5](/filings/0000950170-25-070284.md) | [(10.4) d](/filings/0000950170-25-107987.md) | [(13.5) d](/filings/0001193125-25-277504.md) | [42.0 d](/filings/0001843973-26-000013.md) | [4.1](/filings/0001193125-26-216705.md) | [0.0 d](/filings/0001193125-26-345831.md) | [10.8 d](/filings/0001193125-25-277504.md) | [16.0 d](/filings/0001843973-26-000013.md) | [13.7](/filings/0001193125-26-216705.md) | [5.4 d](/filings/0001193125-26-345831.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.3](/filings/0000950170-25-070284.md) | [19.2](/filings/0000950170-25-107987.md) | [24.3](/filings/0001193125-25-277504.md) | [25.2](/filings/0001193125-26-216705.md) | [27.8](/filings/0001193125-26-345831.md) | [27.8](/filings/0001193125-25-277504.md) | [46.1](/filings/0001193125-26-216705.md) | [53.9](/filings/0001193125-26-345831.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.